WS
TWST icon

Wedbush Securities’s Twist Bioscience TWST Stock Holding History

Wedbush Securities’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,950
Closed -$209K – 1234
2021
Q3 		$209K Hold
1,950
– – 0.01% 1047
2021
Q2 		$260K Sell
1,950
-155
-7% -$18K 0.01% 933
2021
Q1 		$261K Buy
+2,105
New +$320K 0.01% 874

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wedbush Securities's TWST Position: Q4 2021 in Review

Wedbush Securities sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 1,950 shares — an estimated $209K sold.

Wedbush Securities first reported a position in TWST in Q1 2021 and held it in 3 quarters. The position peaked at $261K in Q1 2021. 236 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

  • Wedbush Securities reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
  • Wedbush Securities sold 1,950 Twist Bioscience shares in Q4 2021, an estimated $209K.
  • Wedbush Securities first reported a position in Twist Bioscience in Q1 2021 and held it in 3 quarters.
  • Wedbush Securities's Twist Bioscience position peaked at $261K in Q1 2021.
  • 236 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Wedbush Securities's 13F filing for Q4 2021, filed 13 Jan 2022.